Cadence Biomedical

Cadence Biomedical is an early-stage medical device company that focuses on mobility impairments.

Cadence Biomedical, headquartered in Seattle, WA, is an early stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis are expected in early 2012.